Tomorrow Is Not Likely To Be Same For Amphastar Pharmaceuticals Inc (AMPH)

Amphastar Pharmaceuticals Inc (AMPH) concluded trading on Thursday at a closing price of $43.91, with 0.45 million shares of worth about $19.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.57% during that period and on March 28, 2024 the price saw a gain of about 0.90%. Currently the company’s common shares owned by public are about 48.07M shares, out of which, 34.54M shares are available for trading.

Stock saw a price change of -1.39% in past 5 days and over the past one month there was a price change of -19.78%. Year-to-date (YTD), AMPH shares are showing a performance of -29.01% which increased to 15.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.62 but also hit the highest price of $67.66 during that period. The average intraday trading volume for Amphastar Pharmaceuticals Inc shares is 488.14K. The stock is currently trading -1.69% below its 20-day simple moving average (SMA20), while that difference is down -12.95% for SMA50 and it goes to -17.23% lower than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) currently have 48.07M outstanding shares and institutions hold larger chunk of about 68.39% of that.

The stock has a current market capitalization of $2.11B and its 3Y-monthly beta is at 0.84. PE ratio of stock for trailing 12 months is 16.97, while it has posted earnings per share of $2.59 in the same period. Its PEG reads 0.75 and has Quick Ratio of 1.70 while making debt-to-equity ratio of 0.98. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMPH, volatility over the week remained 2.20% while standing at 3.41% over the month.

Analysts are in expectations that Amphastar Pharmaceuticals Inc (AMPH) stock would likely to be making an EPS of $0.79 in the current quarter, while forecast for next quarter EPS is $0.83 and it is $4.33 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.58 which is $1.01 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.62 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 8.80% while it is estimated to increase by 15.51% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on March 05, 2024 offering an Overweight rating for the stock and assigned a target price of $60 to it. Coverage by BofA Securities stated Amphastar Pharmaceuticals Inc (AMPH) stock as a Neutral in their note to investors on November 17, 2023, suggesting a price target of $63 for the stock. On July 25, 2023, Jefferies Resumed their recommendations, while on October 21, 2022, Jefferies Resumed their ratings for the stock with a price target of $36. Stock get an Overweight rating from CapitalOne on July 29, 2022.

Most Popular

Related Posts